Abnormal glutamate metabolism in amyotrophic lateral sclerosis
- PMID: 2892463
- DOI: 10.1002/ana.410220503
Abnormal glutamate metabolism in amyotrophic lateral sclerosis
Abstract
Glutamate levels were determined in the fasting plasma of 22 patients with early-stage primary amyotrophic lateral sclerosis (ALS) and compared to those of healthy and diseased controls. There was a significant increase (by approximately 100%, p less than 0.0005) in the plasma glutamate of the ALS patients as compared with the controls. Oral glutamate loading (60 mg of monosodium glutamate per kilogram of body weight, taken orally after overnight fasting) resulted in significantly greater elevations in the plasma glutamate and aspartate levels in the ALS patients than in the controls. Glutamate, a potentially neuroexcitotoxic compound, is thought to be the transmitter of the corticospinal tracts and certain spinal cord interneurons. A systemic defect in the metabolism of this amino acid may underlie primary ALS.
Similar articles
-
Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.Ann Neurol. 1990 Jul;28(1):12-7. doi: 10.1002/ana.410280105. Ann Neurol. 1990. PMID: 2375629
-
The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.Ann Neurol. 1988 Sep;24(3):446-9. doi: 10.1002/ana.410240314. Ann Neurol. 1988. PMID: 2906529
-
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.N Engl J Med. 1992 May 28;326(22):1464-8. doi: 10.1056/NEJM199205283262204. N Engl J Med. 1992. PMID: 1349424
-
Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.Muscle Nerve. 2002 Oct;26(4):438-58. doi: 10.1002/mus.10186. Muscle Nerve. 2002. PMID: 12362409 Review.
-
Serotonergic mechanisms in amyotrophic lateral sclerosis.Int J Neurosci. 2006 Jul;116(7):775-826. doi: 10.1080/00207450600754087. Int J Neurosci. 2006. PMID: 16861147 Review.
Cited by
-
Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis.J Neurol Neurosurg Psychiatry. 1994 Jan;57(1):119-20. doi: 10.1136/jnnp.57.1.119-a. J Neurol Neurosurg Psychiatry. 1994. PMID: 8301293 Free PMC article. No abstract available.
-
A fruitful endeavor: modeling ALS in the fruit fly.Brain Res. 2015 May 14;1607:47-74. doi: 10.1016/j.brainres.2014.09.064. Epub 2014 Oct 5. Brain Res. 2015. PMID: 25289585 Free PMC article. Review.
-
Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis.J Neurol. 1989 Dec;236(8):445-7. doi: 10.1007/BF00328503. J Neurol. 1989. PMID: 2614487
-
Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis.J Neurol. 1989 Mar;236(3):127-30. doi: 10.1007/BF00314326. J Neurol. 1989. PMID: 2709061
-
Effect of 8-bromo-cAMP and dexamethasone on glutamate metabolism in rat astrocytes.Neurochem Res. 1990 Nov;15(11):1115-22. doi: 10.1007/BF01101713. Neurochem Res. 1990. PMID: 1982459
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous